Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Feller

Showing results (291-300 of 359) with videos related to

Pageof 36
Sort By:
Anticancer Research|April 30, 2014
Global microRNA profiling of pancreatic neuroendocrine neoplasiasChistoph Thorns, Claudia Schurmann, Niklas Gebauer, et al.
Blood Advances|October 29, 2021
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathwaysHanno M Witte, Axel Künstner, Nadine Hertel, et al.
Clinical Immunology (Orlando, Fla.)|July 17, 2003
Differences in CCR5 expression on peripheral blood CD4+CD28- T-cells and in granulomatous lesions between localized and generalized Wegener's granulomatosisPeter Lamprecht, Hilke Bruhl, Anika Erdmann, et al.
British Journal of Haematology|September 18, 2020
Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphomaJohannes Rieken, Veronica Bernard, Hanno M Witte, et al.
Blood Advances|September 9, 2021
Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphomaNiklas Gebauer, Hanno M Witte, Hartmut Merz, et al.
Blood|March 16, 2004
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHLMichael Pfreundschuh, Lorenz Trümper, Marita Kloess, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 25, 2000
An animal model for anaplastic large cell lymphoma in the immunocompetent syngeneic C57Bl/6 mouseC Bittner, A C Feller, J C Renauld, et al.
Springerplus|January 24, 2014
Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHLKarin Hohloch, Carsten Zwick, Marita Ziepert, et al.
The American Journal of Dermatopathology|August 1, 1997
CD56/neural cell adhesion molecule expression in primary extranodal Ki-1/CD30+ lymphoma. Report of a pediatric case with simultaneous cutaneous and bone localizationsM Paulli, E Boveri, R Rosso, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|January 31, 2020
Mouse Bone Marrow-Derived Mesenchymal Stem Cells Alleviate Perinatal Brain Injury Via a CD8<sup>+</sup> T Cell Mechanism in a Model of Intrauterine InflammationHongxi Zhao, Li Xie, Julia L Clemens, et al.
Pageof 36

Showing results (291-300 of 359) with videos related to

Sort By:
Pageof 36
Anticancer Research|April 30, 2014
Global microRNA profiling of pancreatic neuroendocrine neoplasiasChistoph Thorns, Claudia Schurmann, Niklas Gebauer, et al.
Blood Advances|October 29, 2021
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathwaysHanno M Witte, Axel Künstner, Nadine Hertel, et al.
Clinical Immunology (Orlando, Fla.)|July 17, 2003
Differences in CCR5 expression on peripheral blood CD4+CD28- T-cells and in granulomatous lesions between localized and generalized Wegener's granulomatosisPeter Lamprecht, Hilke Bruhl, Anika Erdmann, et al.
British Journal of Haematology|September 18, 2020
Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphomaJohannes Rieken, Veronica Bernard, Hanno M Witte, et al.
Blood Advances|September 9, 2021
Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphomaNiklas Gebauer, Hanno M Witte, Hartmut Merz, et al.
Blood|March 16, 2004
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHLMichael Pfreundschuh, Lorenz Trümper, Marita Kloess, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 25, 2000
An animal model for anaplastic large cell lymphoma in the immunocompetent syngeneic C57Bl/6 mouseC Bittner, A C Feller, J C Renauld, et al.
Springerplus|January 24, 2014
Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHLKarin Hohloch, Carsten Zwick, Marita Ziepert, et al.
The American Journal of Dermatopathology|August 1, 1997
CD56/neural cell adhesion molecule expression in primary extranodal Ki-1/CD30+ lymphoma. Report of a pediatric case with simultaneous cutaneous and bone localizationsM Paulli, E Boveri, R Rosso, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|January 31, 2020
Mouse Bone Marrow-Derived Mesenchymal Stem Cells Alleviate Perinatal Brain Injury Via a CD8<sup>+</sup> T Cell Mechanism in a Model of Intrauterine InflammationHongxi Zhao, Li Xie, Julia L Clemens, et al.
Pageof 36